Stem cells have different origins and each of them could lead to a particular regeneration and regulation. Different research have continually demonstrated that there are cells safer than others. Also, it has been evidenced that some cells have a superior regeneration capacity than others. In variables as safety, growth potential and cell control, the growing clinic evidence, gathered over the years, have demonstrated that bone marrow specific mesenchymal cells are the most trustworthy.
With time, we have excluded from our treatments the cells that represent a highest risk and that, as international medical evidence have demonstrated, can cause lesions, alterations or pathologies when used for neurodegenerative and internal organ diseases. This cells are those from adipose tissue, from fat. This are cells that contains interleukins or severe inflammatory factors that could cause negative reactions.
Overweight affects patients, leads inflammatory risks and diseases as cardiac alterations, diabetes, neurologic problems, among others. This risks are present in the fat cells and because of that they could react in an undesired way.
The cells need to be studied, analysed and identified in a molecular biology laboratory. They must be evaluated individually and determine if they have, among other things, biologic capacity to regenerate. After this analysis, it is needed to study the potential of the cell to be modulated and specialized to, at last, take tests to this cells that dismiss risk of infection and concomitant diseases that could alter the response to the cell implant in the patient. Our cells are evaluated with telomere charges and pre-surgical and pre-treatment specialized tests, to know the treatment possibilities for the patient according to his or her own cells. To finish, our bone marrow specialized cells are placed after 21 days of cleaning, expansion, identification, modulation and valuation, by a specialist in the affected area or organ.